date,action,name,rate,target
Jan-17-19,Initiated,Stephens,Overweight,
Jan-23-19,Reiterated,BofA/Merrill,Buy,$180 to $185
Jan-24-19,Downgrade,Oppenheimer,Outperform to Perform,
Feb-13-19,Reiterated,Needham,Buy,$145 to $198
Feb-13-19,Reiterated,Canaccord Genuity,Buy,$160 to $190
Feb-13-19,Reiterated,BofA/Merrill,Buy,$185 to $205
Mar-20-19,Resumed,Guggenheim,Buy,
